EE297 Cost-Utility Analysis of Adding Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors or Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists to Standard Therapy in Thai Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Diseas ...
Abstract
Authors
Pattara Leelahavarong Natthakan Chitpim varalak srinonprasert Tanawan Kongmalai